Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia
Clinical trial NCT04415008 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04415008
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2026-10-03
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.